WallStSmart

HCA Healthcare, Inc. (HCA)vsInnovAge Holding Corp (INNV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 7948% more annual revenue ($76.39B vs $949.17M). HCA leads profitability with a 8.9% profit margin vs -1.2%. HCA earns a higher WallStSmart Score of 63/100 (C+).

HCA

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

INNV

Avoid

24

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCASignificantly Overvalued (-85.7%)

Margin of Safety

-85.7%

Fair Value

$286.26

Current Price

$372.13

$85.87 premium

UndervaluedFair: $286.26Overvalued
INNVSignificantly Overvalued (-25.5%)

Margin of Safety

-25.5%

Fair Value

$6.52

Current Price

$7.08

$0.56 premium

UndervaluedFair: $6.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA4 strengths · Avg: 9.3/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.9110/10

Conservative balance sheet, low leverage

Market CapQuality
$86.51B9/10

Large-cap with strong market position

P/E RatioValuation
13.4x8/10

Attractively priced relative to earnings

INNV1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
15.5%8/10

15.5% revenue growth

Areas to Watch

HCA2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

INNV4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Market CapQuality
$1.22B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-9.7%2/10

ROE of -9.7% — below average capital efficiency

EPS GrowthGrowth
-87.8%2/10

Earnings declined 87.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : INNV

The strongest argument for INNV centers on Revenue Growth. Revenue growth of 15.5% demonstrates continued momentum.

Bear Case : HCA

The primary concerns for HCA are Revenue Growth, Altman Z-Score.

Bear Case : INNV

The primary concerns for INNV are Altman Z-Score, Market Cap, Return on Equity.

Key Dynamics to Monitor

HCA profiles as a value stock while INNV is a growth play — different risk/reward profiles.

HCA carries more volatility with a beta of 1.13 — expect wider price swings.

INNV is growing revenue faster at 15.5% — sustainability is the question.

HCA generates stronger free cash flow (895M), providing more financial flexibility.

Bottom Line

HCA scores higher overall (63/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

InnovAge Holding Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

InnovAge Holding Corp. The company is headquartered in Denver, Colorado.

Visit Website →

Want to dig deeper into these stocks?